Cargando…

A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite

As a tumor marker, carbohydrate antigen 24-2 (CA242) is a highly accurate and specific diagnostic indicator for monitoring pancreatic and colorectal cancers. The goal of this study was to create a novel label-free electrochemical immunosensor using a nanocomposite glassy carbon electrode for the det...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xin, Zheng, Xiaodi, Zhang, Zhenhua, Wu, Xiaofan, Sun, Lei, Zhou, Jun, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781068/
https://www.ncbi.nlm.nih.gov/pubmed/31540374
http://dx.doi.org/10.3390/nano9091335
_version_ 1783457292653428736
author Du, Xin
Zheng, Xiaodi
Zhang, Zhenhua
Wu, Xiaofan
Sun, Lei
Zhou, Jun
Liu, Min
author_facet Du, Xin
Zheng, Xiaodi
Zhang, Zhenhua
Wu, Xiaofan
Sun, Lei
Zhou, Jun
Liu, Min
author_sort Du, Xin
collection PubMed
description As a tumor marker, carbohydrate antigen 24-2 (CA242) is a highly accurate and specific diagnostic indicator for monitoring pancreatic and colorectal cancers. The goal of this study was to create a novel label-free electrochemical immunosensor using a nanocomposite glassy carbon electrode for the detection of CA242. Graphene oxide (GO) and polyvinyl pyrrolidone were chosen as the dopants for the preparation of a high-performance reduced-GO-gold-palladium (rGO-Au-Pd) nanocomposite. RGO-Au-Pd was characterized using X-ray diffraction and transmission electron microscopy, revealing that the material exhibited superior electrochemical redox activity and electron transfer ability. The effects of the synthesis method, material concentration, reduction cycle, and pH were investigated to optimize the performance of the immunosensor. As a result of the catalytic activity and biocompatibility of rGO-Au-Pd, the prepared CA242 immunosensor displayed a wide linear range of detection from 0.001 U/mL to 10,000 U/mL with a detection limit of 1.54 × 10(−3) U/mL and a sensitivity of 4.24 μA (log(10)C(CA242))(−1). More importantly, the immunosensor exhibited satisfactory reproducibility and selectivity when detected CA242 in PBS or human serum. The results of our study provide a platform for the development of novel bioassays for use in early cancer diagnosis and promote the application of biosensing technology in the medical field.
format Online
Article
Text
id pubmed-6781068
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67810682019-10-30 A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite Du, Xin Zheng, Xiaodi Zhang, Zhenhua Wu, Xiaofan Sun, Lei Zhou, Jun Liu, Min Nanomaterials (Basel) Article As a tumor marker, carbohydrate antigen 24-2 (CA242) is a highly accurate and specific diagnostic indicator for monitoring pancreatic and colorectal cancers. The goal of this study was to create a novel label-free electrochemical immunosensor using a nanocomposite glassy carbon electrode for the detection of CA242. Graphene oxide (GO) and polyvinyl pyrrolidone were chosen as the dopants for the preparation of a high-performance reduced-GO-gold-palladium (rGO-Au-Pd) nanocomposite. RGO-Au-Pd was characterized using X-ray diffraction and transmission electron microscopy, revealing that the material exhibited superior electrochemical redox activity and electron transfer ability. The effects of the synthesis method, material concentration, reduction cycle, and pH were investigated to optimize the performance of the immunosensor. As a result of the catalytic activity and biocompatibility of rGO-Au-Pd, the prepared CA242 immunosensor displayed a wide linear range of detection from 0.001 U/mL to 10,000 U/mL with a detection limit of 1.54 × 10(−3) U/mL and a sensitivity of 4.24 μA (log(10)C(CA242))(−1). More importantly, the immunosensor exhibited satisfactory reproducibility and selectivity when detected CA242 in PBS or human serum. The results of our study provide a platform for the development of novel bioassays for use in early cancer diagnosis and promote the application of biosensing technology in the medical field. MDPI 2019-09-18 /pmc/articles/PMC6781068/ /pubmed/31540374 http://dx.doi.org/10.3390/nano9091335 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Du, Xin
Zheng, Xiaodi
Zhang, Zhenhua
Wu, Xiaofan
Sun, Lei
Zhou, Jun
Liu, Min
A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title_full A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title_fullStr A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title_full_unstemmed A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title_short A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite
title_sort label-free electrochemical immunosensor for detection of the tumor marker ca242 based on reduced graphene oxide-gold-palladium nanocomposite
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781068/
https://www.ncbi.nlm.nih.gov/pubmed/31540374
http://dx.doi.org/10.3390/nano9091335
work_keys_str_mv AT duxin alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhengxiaodi alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhangzhenhua alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT wuxiaofan alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT sunlei alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhoujun alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT liumin alabelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT duxin labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhengxiaodi labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhangzhenhua labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT wuxiaofan labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT sunlei labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT zhoujun labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite
AT liumin labelfreeelectrochemicalimmunosensorfordetectionofthetumormarkerca242basedonreducedgrapheneoxidegoldpalladiumnanocomposite